AMGEN INC — Director's Dealing 2012

Feb 16, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-02-13

Reporting Person: Harper Sean E (EVP, Research & Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	42150	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Iso (Right to Buy)	$71.88	2013-04-03	Common Stock (1391)		Direct
Nqso (Right to Buy)	$71.88	2013-04-03	Common Stock (16109)		Direct
Nqso (Right to Buy)	$69.78	2014-02-08	Common Stock (14400)		Direct
Nqso (Right to Buy)	$42.13	2015-04-29	Common Stock (6000)		Direct
Nqso (Right to Buy)	$50.44	2016-04-28	Common Stock (16000)		Direct
Nqso (Right to Buy)	$58.43	2020-04-26	Common Stock (24000)		Direct
Nqso (Right to Buy)	$54.69	2021-04-25	Common Stock (21000)		Direct

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,450 RSUs which fully vest on 4/29/2012; 2,250 RSUs which vest in two equal annual installments of 1,125 each commencing 4/28/2012; 3,450 RSUs which vest in three equal annual installments of 1,150 each commencing 4/26/2012; 25,000 RSUs which fully vest on 12/31/2014; and 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These stock options were fully exercisable on April 3, 2010.

F3: These stock options were fully exercisable on February 8, 2011.

F4: These stock options are exercisable in two annual installments of 8,000 each commencing 4/28/2012.

F5: These stock options are exercisable in three annual installments of 8,000 each commencing 4/26/2012.

F6: These stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively.